ONtrepreneurs Program

We partnered with CABHI to present the winners of the 2021 ONtrepreneurs Competition!

In partnership with CABHI, the winners of the 2021 ONtrepreneurs Competition will be announced at CABHI Summit 2021.

Join us for these exciting live events. Discover the latest agetech, neurotech, and healthtech solutions. And you decide: vote for your favourites to win the People’s Choice Awards!

Program Offerings

Up to 10 ONtrepreneurs awarded annually for the 12-month program

  • $50,000

    Non-dilutive fund. OBI does not take equity or IP

  • Training

    Training opportunities to build your venture

  • Mentorship

    1:1 mentorship from an expert in your sector

  • OBI Network

    Value-add opportunities as part of our network

Impact of our work

The ONtrepreneurs program is fueling the growth of the neurotech cluster.

  • 61

    ONtrepreneurs*

  • 106M

    Follow-on Investments*

  • 35X

    Return on Investments*

NeuroQore’s First Dawn – A Solution for Treatment-Resistant Depression

As a teenager, Mehran Talebinejad, Co-Founder & CEO, NeuroQore, got interested in understanding the brain, and particularly depression, for one reason alone – his grandma. He wanted to offer help for her depression but due to a lack of care services and delays in finding the right drug treatment, coupled with the stigma associated with depression, he was unable to support her in the way he wanted. It was in that moment that he decided to take matters into his own hands – someone had to fundamentally transform mental health treatments – and it had to be him.

Epineuron Technologies Closes Financing for its Breakthrough Nerve Regeneration Device

Epineuron Technologies, Inc., a bioelectronic medicine company, announced the completion of a financing round to support production development and clinical validation for its neuroregenerative technology - designated a breakthrough device by the FDA.

Spiderwort Closes $3.4 Million Cad in Seed Financing

Spiderwort, an Ottawa-based healthtech and biomaterials startup, has raised a seed round of funding at $3.4 million CAD ($2.5 million USD).

Spiderwort is developing a new biomaterial that uses plant-derived cellulose to create a variety of “scaffold architectures” for regenerative medicine. It is currently in the pre-clinical stage of this product. The startup plans to use the funding to continue its work towards clinical trials, which it called “key” to bringing its biomaterial to market.

Bringing New Technology to Life - A Giant Leap for Elder Care

In the most rewarding relationships, everyone brings something to the table. When OBI partners with other organizations, we consider the ways each party can be of value to a mutually shared goal.

The Welbi platform is a perfect example. The innovation of an innovative Ottawa startup, Welbi helps senior living communities reduce social isolation, and acts as a personal assistant automating administrative tasks, providing alerts and making recommendations to staff so that they can better tailor their services to the needs of their community.

Neurotech Spotlight

NeuroQore’s First Dawn – A Solution for Treatment-Resistant Depression

As a teenager, Mehran Talebinejad, Co-Founder & CEO, NeuroQore, got interested in understanding the brain, and particularly depression, for one reason alone – his grandma. He wanted to offer help for her depression but due to a lack of care services and delays in finding the right drug treatment, coupled with the stigma associated with depression, he was unable to support her in the way he wanted. It was in that moment that he decided to take matters into his own hands – someone had to fundamentally transform mental health treatments – and it had to be him.

Investors

Private and institutional investors interested in learning more about the neurotech industry or considering investments in this space can gain access to OBI’s investor platform with detailed profiles of OBI’s portfolio companies. To learn more, please contact: IndustryRelations@braininstitute.ca

Neurotechnology Startups

If you are commercializing a neurotechnology we want to hear from you. Contact us to learn more about the neurotech industry and OBI’s commercialization programs and opportunities: IndustryRelations@braininstitute.ca

*Cumulative total as of Dec 31, 2020